NANEXA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.88 SEK | -0.90% |
|
+2.09% | -28.46% |
| Jun. 28 | Nanexa AB Announces Chief Financial Officer Changes | CI |
| Jun. 11 | Nanexa AB Announces That First Patient Dosed in Nanexa's Phase I Trial of NEX-22 in Type 2 Diabetes | CI |
- Stock Market
- Equities
- NANEXA Stock
- News Nanexa AB
- Analyst Reco.
